USRM - U.S. Stem Cell, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0188
+0.0012 (+7.12%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.0176
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume902,167
Market Cap7.042M
Beta (3Y Monthly)11.14
PE Ratio (TTM)N/A
EPS (TTM)-0.0040
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.40
Trade prices are not sourced from all markets
  • USRM Chief Science Officer Featured on One Radio Network
    PR Newswire8 days ago

    USRM Chief Science Officer Featured on One Radio Network

    SUNRISE, Fla., Jan. 15, 2019 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer has been featured on Patrick Timpone's One Radio Network. Dr. Kristin Comella, who has been frequently published in the scientific literature on the use and application of autologous (a patient's own) adipose-derived stem cells, will speak on her expertise in the autologous stem cell space. Americans' interest in stem cell therapy continues to grow, demand for Dr. Comella to present on the topic continues to increase.

  • USRM announces U.S. Stem Cell Clinic Expansion of Products and Services
    PR Newswire2 months ago

    USRM announces U.S. Stem Cell Clinic Expansion of Products and Services

    Increasing Market Demand for Regenerative Therapies Drives Diversification SUNRISE, Fla. , Dec. 6, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc., a leader in regenerative medicine products and services, today ...

  • Dr. Kristin Comella Featured on Robert Scott Bell Show
    PR Newswire2 months ago

    Dr. Kristin Comella Featured on Robert Scott Bell Show

    SUNRISE, Fla., Nov. 9, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, has appeared on the Robert Scott Bell Show to talk about health freedom and autologous stem cell therapy. The interview can be listened to in its entirety here.

  • USRM Posts 25% Nine Month Revenue Increase From 3Q 2017
    PR Newswire3 months ago

    USRM Posts 25% Nine Month Revenue Increase From 3Q 2017

    SUNRISE, Fla., Nov. 7, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced third quarter results for this year and comparatively from last year, for the nine months ended Sept. 30, 2018. As has been the trend for the past several years, revenue continues to rise -- almost $1M or 25% for the period compared to the same period last year --  from $4.04M in 3Q 2017 to $5.03M in 3Q 2018.  Gross profit margins also increased, $723K or 26.8%, from $2.69M to $3.42M for the same time period.  Operating expenses decreased $850K or 42%, from $2.02M to $1.17M.  Net Loss from operations decreased $838K or 79.3%, from $1M to $218K during the same nine months ended this year versus last.

  • Adipose Stem Cells Demonstrate Effectiveness in Repairing Decubitus Ulcers
    PR Newswire3 months ago

    Adipose Stem Cells Demonstrate Effectiveness in Repairing Decubitus Ulcers

    SUNRISE, Fla., Oct. 9, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has published in the scientific literature that it has successfully used autologous stem cells from fat tissue to repair decubitus ulcers. A decubitus ulcer is a wound on the skin also known as a pressure ulcer which typically occurs over bony skin, such as buttocks.  These wounds can be common in spinal cord injury patients with limited mobility.  The number of patients with pressure ulcers is estimated to be between 1.3 to 3 million in the United States.  The number of hospitalizations as a result of decubitus ulcers has increased by more than 75% between 1993 and 2006.

  • USRM Chief Science Officer Featured on YourVoice™ America
    PR Newswire4 months ago

    USRM Chief Science Officer Featured on YourVoice™ America

    SUNRISE, Fla., Oct. 1, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, was featured on this week's Sunday edition of YourVoice™ America -- a fast-growing, internet broadcasting platform reaching millions of people each month. YourVoice™ America was founded in the wake of (weekday host) Bill Mitchell's 90+ million Twitter hits on election night and become a strong platform for President Trump and the MAGA message.   The "Faith & Freedom" edition, hosted by successful business mogul Leigh Valentine, covers political, spiritual and lifestyle issues on Sunday nights at 8 PM EST.

  • Dr. Kristin Comella Joins Top Docs in Fix for Female Hormones Seminar
    PR Newswire4 months ago

    Dr. Kristin Comella Joins Top Docs in Fix for Female Hormones Seminar

    SUNRISE, Fla., Sept. 26, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, will be featured alongside other top doctors in the upcoming webinar summit, the Fix for Female Hormones.

  • USRM Hires Senior VP of US & International Sales
    PR Newswire4 months ago

    USRM Hires Senior VP of US & International Sales

    SUNRISE, Fla., Sept. 11, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced Phil Posa has joined its executive management team as Senior Vice President of U.S. & International Sales. Posa, who brings more than 30 years of experience in the pharmaceutical, medical device and regenerative spaces, most recently served as an Executive and CEO at Stem Cell Centers of Idaho, where he assisted in the launch and management of new and existing clinics -- at a rapid growth rate of approximately one clinic per month.

  • USRM Posts Profitable Results for Second Quarter 2018
    PR Newswire6 months ago

    USRM Posts Profitable Results for Second Quarter 2018

    SUNRISE, Fla., Aug. 8, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced results for its second quarter in 2018 -- the 10th consecutive quarter where revenue has increased. For the quarter ending June 30, 2018, the Company posted a revenue increase of 31% to $1.82m, up from $1.39m for the second quarter of last year.  Revenue also increased for the six months ended June 30, 2018, to $3.53m, up 39% from $2.54m for the same period last year. Profit margin for the second quarter also increased, to 69% from 67% for the same period last year, and profit margin for the first six months of this year increased to 70% from 68% in the first six months of 2017.  Gross profit was also up for both periods, with a 34% increase to $1.25m from $934k for the second quarter, and a 43% increase to $2.46m from $1.73m for the six-month period.

  • Stem Cells Shows Promise For Repairing Torn Meniscus
    PR Newswire6 months ago

    Stem Cells Shows Promise For Repairing Torn Meniscus

    Results are published in the scientific publication the Journal of Medical Cases, and is authored by USRM Chief Science Officer Dr. Kristin Comella and colleagues Dr. Scott Greenberg of the Magaziner Center for Wellness, and Dr. Laura Ross of Ross Orthopedic.

  • 'Renewing Our Heroes' to Provide USRM Stem Cell Protocol to First Responders
    PR Newswire8 months ago

    'Renewing Our Heroes' to Provide USRM Stem Cell Protocol to First Responders

    SUNRISE, Fla., June 5, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced Renewing Our Heroes  -- a charitable health initiative established to provide first responders and other civil service personnel with access to alternative medical care they would otherwise be unable to obtain -- will now offer USRM stem cell procedures and protocols to its recipients following injuries and conditions that occur in the line of duty. Established by Joseph Radich, Founder and Clinical Director of  RenewU Medical and son of an actively serving New York City firefighter, Renewing Our Heroes was created as a charitable health initiative to help individuals who voluntarily and without hesitation put their bodies, minds, families and lives on the line every day.

  • USRM Chief Science Officer to Present at Fifth Annual Cell Surgical World Conference
    PR Newswire8 months ago

    USRM Chief Science Officer to Present at Fifth Annual Cell Surgical World Conference

    SUNRISE, Fla., June 1, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, will be presenting at the Fifth Annual Cell Surgical World Conference in Beverly Hills this Saturday, June 2. Dr. Comella is, to the Company's best knowledge, one of the most published scientists in the clinical use of fat derived autologous stem cells.  Her work in the application of autologous (a patient's own) stem cell therapy is unparalleled, and includes autoimmune, neurodegenerative, orthopedic and degenerative conditions.  To date, the company has worked with more than 10,000 patients and trained more than 700+ physicians worldwide.

  • USRM Chief Scientist Talks Stem Cell Journey, Autologous Stem Cells with 'Something Significant' Happy Living Podcast
    PR Newswire8 months ago

    USRM Chief Scientist Talks Stem Cell Journey, Autologous Stem Cells with 'Something Significant' Happy Living Podcast

    SUNRISE, Fla., May 17, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, is featured in the 'Something Significant' Happy Living podcast with former NFL player Matt Gersper, where she discusses the inception of her work more than 19 years ago and how she and USRM's development of novel, therapeutic adipose (fat derived) stem cell treatments, is changing lives. The interview is available for complementary playback here.

  • World Bodybuilding Expert Interviews USRM Chief Science Officer At Paleo F(X) Conference
    PR Newswire8 months ago

    World Bodybuilding Expert Interviews USRM Chief Science Officer At Paleo F(X) Conference

    SUNRISE, Fla., May 15, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the release of USRM Chief Science Officer Dr. Kristin Comella's interview with Ben Pakulski -- a world bodybuilding expert who last year received autologous stem cell therapy that successfully treated torn muscles.  Listen to the interview here, or at https://www.benpakulski.com/comella. Dr. Comella, a world renowned expert in the development and clinical application of autologous stem cell products and therapies, is one voice in a growing movement recognizing the power of regenerative medicine and, in particular, autologous stem cell therapy.

  • Autologous Stem Cell Therapy May Hold Key to Regeneration
    PR Newswire8 months ago

    Autologous Stem Cell Therapy May Hold Key to Regeneration

    SUNRISE, Fla., May 14, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the release of USRM Chief Science Officer Dr. Kristin Comella's Stem Cell 101 Webinar from last Friday, now available for complimentary playback via live link, http://www.brainshark.com/Stemlogix/vu?pi=zGWzp5LSBz5OLvz0. Dr. Comella, a world renowned expert in the development and clinical application of autologous stem cell products and therapies, is one voice in a growing movement recognizing the power of regenerative medicine and, in particular, autologous stem cell therapy.

  • USRM Chief Science Officer, Dr. Kristin Comella, Featured on Health Boot Camps' Webinar
    PR Newswire8 months ago

    USRM Chief Science Officer, Dr. Kristin Comella, Featured on Health Boot Camps' Webinar

    SUNRISE, Fla., May 10, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions,  today announced its Chief Science Officer, Dr. Kristin Comella, is a featured guest on Health Boot Camps' "The Fountain of Health Has Been Found: An Interview with Dr. Kristin Comella," now available on podcast here. Dr. Comella is extensively published in the scientific literature in the practical application of autologous stem cell therapy.  Last month, she and her team were the first in the world to publish in-human results in scientific literature of adipose stem cell therapy significantly reducing psoriasis -- a condition that affects 7 million plus Americans annually.

  • U.S. Department of Justice Files Lawsuit at Request of FDA to Stop U.S. Stem Cell Clinic from Performing Autologous Stem Cell Procedure
    PR Newswire9 months ago

    U.S. Department of Justice Files Lawsuit at Request of FDA to Stop U.S. Stem Cell Clinic from Performing Autologous Stem Cell Procedure

    USRM Will Vigorously Defend Medical Freedom of Americans SUNRISE, Fla. , May 9, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a world leader in the development of proprietary, physician-based ...

  • U.S. Stem Cell Reports First Quarter Results
    PR Newswire9 months ago

    U.S. Stem Cell Reports First Quarter Results

    SUNRISE, Fla., May 9, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced first quarter results for 2018. For two consecutive years, USRM has sustained substantial revenue growth, which may be attributable to an increased awareness of stem cell therapy, as Americans seek alternatives to pain management and opioids.

  • USRM Chief Science Officer to Host Webinar on Autologous Stem Cell Therapy
    PR Newswire9 months ago

    USRM Chief Science Officer to Host Webinar on Autologous Stem Cell Therapy

    MIAMI, May 8, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, will host a live webinar designed to inform the public about the benefits and science behind autologous stem cell therapy. "Stem Cells 101: A Patient's Guide to Autologous Stem Cell Therapy" will livestream Friday, May 11th, at twelve noon EST.  Participants who livestream the webinar may also post questions to Dr. Comella, who will answer as many livestream questions as she can during the session. "Stem Cells 101: A Patient's Guide to Autologous Stem Cell Therapy"  will also be recorded and posted following the livestream on U.S. Stem Cell's website and in social media.

  • USRM Chief Science Officer Featured in Live Interview for Biohacker Summit in Helsinki
    PR Newswire9 months ago

    USRM Chief Science Officer Featured in Live Interview for Biohacker Summit in Helsinki

    MIAMI, May 3, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announced its Chief Science Officer, Dr. Kristin Comella, appeared live today as a featured guest for the Biohacker Summit blog -- a component of the Biohacker Center in Helsinki, Finland.  Free online viewing of the live interview on stem cells is available in its entirety here. Dr. Comella, who has more than 20+ years' experience and is a world renowned expert in the development and clinical practice of stem cell products and therapies, is extensively published in the scientific literature in the practical application of autologous (a patient's own) stem cell therapy.  Last month, Dr. Comella and her team were the first in the world to publish in the scientific literature in-human results of adipose stem cell therapy significantly reducing psoriasis — a condition that affects more than 7 million Americans annually.

  • Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales
    PR Newswire9 months ago

    Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales

    SUNRISE, Fla., April 24, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced sales figures for 2016 and 2017 for both its AdipoCell TM proprietary stem cell kit and the stem cell banking businesses -- both of which demonstrate steady growth.

  • USRM Announces 2017 Financial Results
    PR Newswire9 months ago

    USRM Announces 2017 Financial Results

    SUNRISE, Fla., April 16, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today filed a Form 10-K reporting year-end numbers for 2017, which reflect continued growth and increased cash flow from operations. Revenue for 2017 increased 79% to $5.5m -- up $2.4m from $3.1m in 2016.  Revenue also increased 53% in the fourth quarter of 2017 to $964k from $508k in the same quarter in 2016.  Net gross profit in 2017 increased 72% to $2.1m from $1.5m in the previous year.  For the fourth quarter 2017, net gross profit was also up while overall debt decreased.

  • PR Newswire9 months ago

    Newest Clinic Opens Today at The Villages in Central Florida

    SUNRISE, Fla., April 9, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the opening its first USRM clinic in North Central Florida. The U.S. Stem Cell Clinic of The Villages will offer alternatives to chronic pain management using USRM's proprietary AdipocellTM product in a minimally invasive procedure utilizing a patient's own (autologous) stem cells.  Medical director for the clinic will be Dr. Rosemary Daly, an interventional spine/pain management physician who is board certified in Anesthesiology and Pain Medicine.  Dr. Daly, who graduated from the New York College of Osteopathic Medicine, is also medical director for the Regenerative Wellness Clinic (RWC) in West Palm Beach, which is also in the USRM network of stem cell treatment centers.

  • USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells
    PR Newswire10 months ago

    USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells

    SUNRISE, Fla., March 21, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has published in the scientific literature that it has successfully demonstrated a 99 percent reduction in-human of the severity of psoriasis using a patient's autologous stem cells. To the best of USRM management's knowledge, this is the first result in the world published using stromal vascular fraction (SVF) and autologous stem cells in the successful treatment of psoriasis.

  • PR Newswire10 months ago

    USRM Chief Science Officer to Present at Paleo f(x) Ancestral Healing Conference in Austin, Texas

    SUNRISE, Fla., March 20, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, is pleased to announce its Chief Science Officer, Dr. Kristin Comella, has accepted an invitation to present at the 2018 Paleo f(x) Ancestral Healing Conference Friday, April 27, at the Palmer Events Center in Austin, Texas. Dr. Comella will present "Regenerative Medicine: The Future of Medicine is Here," at 4:25 p.m. CST at the Kegenix Paleo On Ramp Stage.  Her presentation will be livestreamed on the USRM facebook page, follow to receive a live notification.